Actos Pioglitazone Hydrochloride

Actos is a brand of pioglitazone hydrochloride, a medication used primarily in the treatment of type 2 diabetes. Originally developed by the Japanese pharmaceutical giant Takeda Pharmaceutical Company, the brand has been licensed and distributed globally through various partnerships and regional pharmaceutical companies.

In the Middle East and North Africa (MENA) region, the prominent pharmaceutical company Hikma Pharmaceuticals manufactures and markets this medication. Hikma often operates under licensing agreements or local manufacturing protocols to provide essential treatments in their core markets. While the brand origin remains Japanese, the actual physical production of the unit shown likely occurs in one of Hikma's regional manufacturing hubs, such as those in Jordan, Cairo, or Algeria, depending on the specific domestic market needs.